ReleaseWire

Global Microfluidic Device Market Is Expected to Grow at a CAGR of 22.8% by 2019 - Persistence Market Research

North America dominates the global microfluidic devices market. Rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market.

Posted: Friday, October 31, 2014 at 9:43 AM CDT

New York, NY -- (SBWire) -- 10/31/2014 --According to a new market report published by Persistence Market Research “Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019” the global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.

Browse the full report Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019 at http://www.persistencemarketresearch.com/market-research/microfluidic-devices-market.asp

Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. In addition, microfluidic proteomic devices are increasingly being used to quantify and identify proteins and to study interactions of different proteins with reagent in array. Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.

In North America, rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Usage of microfluidic technology in North America is high compared to other regions of the world due to its early adoption and multiple applications in different industries.

In Europe, the microfluidic device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of microfluidic devices in the region.

However, Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems. Asia is one of the producers of generic drugs, which require microfluidic devices for toxicity testing of drugs.

Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Inc, Fluidigm Corporation and Johnson & Johnson are some of the major players of microfluidic device market.

The microfluidic device market is segmented as follows:

1) Microfluidic Device Market, By Material
a) Glass
b) Polymer
c) Silicon

2) Microfluidic Device Market, By Application
a) Clinical and veterinary diagnostics
b) Point of care testing
c) Pharmaceutical and life science research
d) Drug delivery
e) Analytical devices
f) Environment and industrial

3) Microfluidic Device Market, By Industry
a) In-vitro diagnostics
b) Pharmaceuticals
c) Medical devices
4) Microfluidic Device Market, by Geography
a) North America
U.S.
Canada
b) Europe
Germany
France
Italy
Spain
U.K.
Belgium
Netherlands
Switzerland
c) Asia
Japan
China
India
d) Rest of the World (Row)

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Addie Thomas
305 Broadway
7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com